AU2003217357A1 - Generation of new insulin cells from progenitor cells present in adult pancreatic islets - Google Patents

Generation of new insulin cells from progenitor cells present in adult pancreatic islets

Info

Publication number
AU2003217357A1
AU2003217357A1 AU2003217357A AU2003217357A AU2003217357A1 AU 2003217357 A1 AU2003217357 A1 AU 2003217357A1 AU 2003217357 A AU2003217357 A AU 2003217357A AU 2003217357 A AU2003217357 A AU 2003217357A AU 2003217357 A1 AU2003217357 A1 AU 2003217357A1
Authority
AU
Australia
Prior art keywords
generation
pancreatic islets
cells
new insulin
adult pancreatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003217357A
Other versions
AU2003217357A8 (en
Inventor
Teitelman Gladys
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation of State University of New York
Original Assignee
Research Foundation of State University of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation of State University of New York filed Critical Research Foundation of State University of New York
Publication of AU2003217357A8 publication Critical patent/AU2003217357A8/en
Publication of AU2003217357A1 publication Critical patent/AU2003217357A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0676Pancreatic cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/34Sugars
AU2003217357A 2002-02-07 2003-02-07 Generation of new insulin cells from progenitor cells present in adult pancreatic islets Abandoned AU2003217357A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35571502P 2002-02-07 2002-02-07
US60/355,715 2002-02-07
PCT/US2003/003859 WO2003066832A2 (en) 2002-02-07 2003-02-07 Generation of new insulin cells from progenitor cells present in adult pancreatic islets

Publications (2)

Publication Number Publication Date
AU2003217357A8 AU2003217357A8 (en) 2003-09-02
AU2003217357A1 true AU2003217357A1 (en) 2003-09-02

Family

ID=27734554

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003217357A Abandoned AU2003217357A1 (en) 2002-02-07 2003-02-07 Generation of new insulin cells from progenitor cells present in adult pancreatic islets

Country Status (2)

Country Link
AU (1) AU2003217357A1 (en)
WO (1) WO2003066832A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790637B2 (en) 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
US7875272B2 (en) 2003-06-27 2011-01-25 Ethicon, Incorporated Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
US9572840B2 (en) 2003-06-27 2017-02-21 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
US8703121B2 (en) 2003-06-27 2014-04-22 DePuy Synthes Products, LLC Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
US9592258B2 (en) 2003-06-27 2017-03-14 DePuy Synthes Products, Inc. Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
CA2589063C (en) 2004-12-23 2016-08-09 Ethicon Incorporated Treatment of parkinson's disease and related disorders using postpartum derived cells
US9175261B2 (en) 2005-12-16 2015-11-03 DePuy Synthes Products, Inc. Human umbilical cord tissue cells for inhibiting adverse immune response in histocompatibility-mismatched transplantation
US9125906B2 (en) 2005-12-28 2015-09-08 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
AU2009327384B2 (en) 2008-12-19 2014-07-10 DePuy Synthes Products, LLC Treatment of lung and pulmonary diseases and disorders
US10179900B2 (en) 2008-12-19 2019-01-15 DePuy Synthes Products, Inc. Conditioned media and methods of making a conditioned media
EP2411504B1 (en) 2009-03-26 2017-05-10 DePuy Synthes Products, Inc. Human umbilical cord tissue cells as therapy for alzheimer's disease
US9611513B2 (en) 2011-12-23 2017-04-04 DePuy Synthes Products, Inc. Detection of human umbilical cord tissue derived cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116753A (en) * 1991-07-30 1992-05-26 The Salk Institute For Biological Studies Maintenance of pancreatic islets
US5858973A (en) * 1994-02-23 1999-01-12 The General Hospital Corporation Transcription factor and uses therefor
US5958404A (en) * 1994-04-13 1999-09-28 Research Corporation Technologies, Inc. Treatment methods for disease using co-localized cells and Sertoli cells obtained from a cell line
US5916790A (en) * 1995-03-03 1999-06-29 Metabolex, Inc. Encapsulation compositions, and methods

Also Published As

Publication number Publication date
AU2003217357A8 (en) 2003-09-02
WO2003066832A3 (en) 2003-12-24
WO2003066832A2 (en) 2003-08-14

Similar Documents

Publication Publication Date Title
AU2003268534A1 (en) Cd56 positive human adult pancreatic endocrine progenitor cells
IL144654A0 (en) Pancreatic progenitor cells, methods and uses related thereto
AU2003217357A1 (en) Generation of new insulin cells from progenitor cells present in adult pancreatic islets
WO2005063971A3 (en) Definitive endoderm
SG170068A1 (en) Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production
AU2003298016A8 (en) Homologous recombination in multipotent adult progenitor cells
EP1224259A4 (en) Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
AU2003271976A1 (en) Hydrogen fuel cell systems
WO2006054305A3 (en) Populations of expanded and re-differentiated adult islet beta cells capable of producing insulin and methods of generating same
EP1513538A4 (en) Novel methods for the delivery of polynucleotides to cells
AU2002367627A1 (en) Intermittent cooling of fuel cell
AU2003250398A1 (en) Fuel cell direct water injection
EP1709151A4 (en) Compositions and methods for propagation of neural progenitor cells
AU2003266282A1 (en) Compositions comprising muscle progenitor cells and uses thereof
IL159777A0 (en) Production of transduced hematopoietic progenitor cells
AU2003272598A1 (en) Th1 cell adoptive immunotherapy
AU2003231868A1 (en) Fuel cell reactant supply
WO2003012084A3 (en) Human glucose-dependent insulin-secreting cell line
WO2005001042A3 (en) Smooth muscle progenitor cells
AU3227000A (en) Methods of inducing insulin positive progenitor cells
AU2003221637A1 (en) Production of neural progenitor cells
AU2003287188A1 (en) Activation of hcv-specific cells
AU2003246498A1 (en) Modulation of mesenchymal cells via iga-receptors
AU2003229987A1 (en) Hydrogen generation
AU2003903583A0 (en) Production and storage of hydrogen

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase